USANA Health Sciences, Inc. (USNA) Company Overview

US | Consumer Defensive | Packaged Foods | NYSE

What does USANA Health Sciences do?

USANA Health Sciences, Inc. is a New York Stock Exchange-listed wellness company that develops and markets supplements, functional foods, protein products, personal care, and skincare. Founded in 1992, it has evolved from a direct-selling supplement manufacturer into an omnichannel portfolio spanning Brand Partners, preferred customers, subscriptions, marketplaces, and large retailers. Its investor-relations overview emphasizes global wellbeing; the analytical question is whether newer channels can offset declining legacy-network participation.

$925.3M
FY2025 consolidated net sales
25
Global markets cited by the company in 2026
404,000
Core Nutritional active customers, Q1 2026
186,000
Hiya active monthly subscribers, Q1 2026

A portfolio organized by channel and customer behavior

Effective January 4, 2026, USANA reorganized into Core Nutritional, Hiya, and Rise. Core sells supplements and personal-care products through Brand Partners and Preferred Customers globally. Hiya sells children’s wellness products mainly through subscriptions, with retail expansion. Rise sells protein snacks and drinks through national and club retailers. The 2025 Form 10-K shows that USANA is no longer defined by one channel, although Core remains the revenue and profit engine.

Business Primary channel Core customer Economic role
Core Nutritional Direct selling and customer e-commerce Brand Partners and Preferred Customers High gross margin, global scale, and the group’s current profit engine
Hiya Subscription-led direct-to-consumer plus emerging retail Parents purchasing children’s wellness products Recurring revenue and customer data, but substantial marketing expense
Rise National retail, club retail, and direct-to-consumer Mainstream protein and functional-snack consumers Fast channel expansion with materially lower gross margins

How does USANA make money?

The model starts with product sales. Core revenue rises through active-customer growth, higher spend, or both. Brand Partners may resell products and earn incentives; Preferred Customers buy for personal use. In Q1 2026, Brand Partners generated about 50% of Core sales but represented 41% of active customers, versus 59% for Preferred Customers. Recruiting, retention, incentives, and consumption therefore influence the same revenue stream.

1. Formulate and manufacture
USANA applies internal R&D, quality control, and manufacturing to supplements and personal-care products.
2. Reach customers
Brand Partners, websites, subscriptions, marketplaces, and retail chains create multiple acquisition routes.
3. Generate repeat orders
Core customer routines and Hiya subscriptions seek to turn health products into recurring purchases.
4. Fund incentives and marketing
Brand Partner incentives apply to Core Nutritional; digital advertising is especially important for Hiya.
5. Reinvest or return cash
Cash supports product development, working capital, acquisitions, facilities, debt service, and repurchases.

Why channel mix changes margin quality

Core carried an 82.0% gross margin in Q1 2026 but Brand Partner incentives equaled 43.4% of segment sales. Hiya’s gross margin was 68.9%, while SG&A was 77.0% of sales because acquisition spending and amortization remained heavy. Rise produced only a 7.1% gross margin as Protein Pop entered large retailers. Omnichannel growth can therefore broaden reach while diluting consolidated margin.

Which segments and products matter most?

Core Nutritional
$204.4M
81.7% of Q1 2026 sales; $18.2M segment operating earnings.
Hiya
$32.2M
12.8% of Q1 2026 sales; $2.6M segment operating loss.
Rise
$13.7M
5.5% of Q1 2026 sales; $1.8M segment operating loss.
Q1 2026 revenue mix by reportable segment
$250.2M
Core Nutritional — $204.4M — 81.7%
Hiya — $32.2M — 12.8%
Rise — $13.7M — 5.5%
Core Nutritional still supplies more than four-fifths of consolidated sales and all positive segment operating earnings. Period: quarter ended April 4, 2026.

Product concentration is meaningful but not singular

In Q1 2026, USANA Nutritionals represented 71% of total product revenue, Foods 6%, personal care and skincare 5%, Hiya 13%, and Rise 5%. Within Core Nutritional, Optimizers represented 72% of segment product sales. In Hiya, the Kids Daily Multivitamin contributed 55% of product revenue, followed by the probiotic at 14%, Greens and Superfoods at 12%, and Bedtime Essentials at 11%. Rise was even more concentrated: Protein Pop, launched in the third quarter of 2025, generated 75% of segment product revenue in Q1 2026.

Total product revenue mix — Q1 2026
USANA Nutritionals — 71%
Hiya — 13%
USANA Foods — 6%
Personal care and skincare — 5%
Rise — 5%
The legacy nutrition portfolio remains the center of product demand, while Hiya and Rise create new demographic and channel exposure. Period: Q1 2026.

What does USANA’s latest quarter show?

The Q1 2026 earnings release reported consolidated sales of $250.2 million, up only 0.3% year over year. Foreign exchange added roughly $8.1 million, so constant-currency sales fell 3.0%. Rise added $12.0 million of incremental revenue, but Core Nutritional declined $6.4 million and Hiya declined $4.9 million. The quarter therefore demonstrates both the promise and the limitation of diversification: new retail distribution stabilized the top line, while the established customer and subscription engines weakened.

$250.2M
Net sales, Q1 2026; +0.3% reported and -3.0% constant currency
$13.9M
Operating earnings, Q1 2026; 5.5% operating margin
$7.5M
Net earnings attributable to USANA, Q1 2026; -20.1%
$0.41
Diluted EPS, Q1 2026 versus $0.49 in Q1 2025
$9.8M
Operating cash flow, Q1 2026
$7.1M
Approximate free cash flow, Q1 2026: operating cash flow less $2.6M capex
Metric Q1 2026 Q1 2025 Interpretation
Net sales $250.2M $249.5M Reported stability depended on FX and Rise growth.
Gross margin 76.2% 79.0% Retail mix and Core manufacturing inefficiency pressured margin.
Operating earnings $13.9M $15.7M Cost realignment helped SG&A, but segment losses remained.
Pretax earnings $15.5M $16.7M Other income partly supported pretax results.
Effective tax rate 55.0% 44.5% Income mix and lower consolidated earnings reduced conversion to net income.
Cash and equivalents $162.8M $158.4M at FY2025 year-end Liquidity increased despite working-capital and compensation payments.
76.2%
Q1 2026 consolidated gross margin. The 280-basis-point year-over-year decline illustrates how Rise’s retail expansion can add revenue faster than gross profit. The full quarterly filing is available in USANA’s Form 10-Q.

How did strategic evolution reshape USANA?

USANA’s history combines scientific-product credibility with broader distribution. Its official company story emphasizes cellular science; the filings reveal a second theme—reducing dependence on one acquisition system.

  1. 1992
    Myron Wentz founded USANA, establishing the science-based supplement identity that still underpins pricing, manufacturing, and brand claims.
  2. 2010
    The BabyCare transaction created a dedicated China platform. China later became USANA’s largest national market, but also its most consequential regulatory exposure.
  3. 2022
    USANA acquired Rise and Oola, beginning a deliberate move beyond the traditional supplement network into functional foods, retail, and adjacent wellness.
  4. 2023
    Operations began in India, adding a long-duration geographic growth option with local sourcing and manufacturing requirements.
  5. 2024
    USANA acquired a 78.85% controlling interest in Hiya, adding a subscription-led children’s wellness platform and a future obligation framework for the remaining minority interest.
  6. 2025
    Protein Pop launched and accelerated Rise retail sales; USANA also rolled out an enhanced Brand Partner compensation plan and recorded cost-realignment and impairment charges.
  7. 2026
    Rise became a separate reportable segment, while Kevin Guest returned as CEO and remained chairman, signaling sharper accountability for the omnichannel transformation.
The history explains today’s valuation tension: USANA is defending a mature direct-selling cash engine while funding subscription and retail businesses that have not yet matched its profitability.

What gives USANA a competitive advantage?

Manufacturing, formulation, and quality control

USANA’s 354,000-square-foot Salt Lake City headquarters combines manufacturing, quality control, distribution, administration, and R&D. Vertical integration supports quality assurance, formulation speed, and supply-chain visibility. FY2025 R&D expense was $10.7 million, with expertise spanning nutrition, cellular biology, microbiome science, foods, cosmetics, and clinical research. The advantage is a capability system, not an impenetrable patent moat.

Relationship distribution and recurring routines

Core benefits from a long-established Brand Partner network, local operations, and repeat-use products. Hiya adds subscriptions, refill economics, and customer data. Recurring orders generally carry better margins than first orders because discounts and bottle-related shipping costs are lower. Both systems require replenishment—Brand Partner activity in one case and paid digital acquisition in the other.

Product and quality capability
Strong
Internal R&D and manufacturing support differentiation, though products face many substitutes.
Distribution resilience
Moderate
Multiple channels are valuable, but Core active customers and Hiya subscribers declined year over year in Q1 2026.
Switching costs
Limited
Consumer wellness products are easy to replace; habit, trust, and relationships matter more than contractual lock-in.
Balance-sheet support
Strong
Q1 2026 cash of $162.8M substantially exceeded $14.0M of credit-facility debt.

Who competes with USANA?

USANA competes for consumer spending, productive distributors, digital subscribers, and retail shelf space. Its official peer group includes Nu Skin, Herbalife, LifeVantage, Medifast, Nature’s Sunshine, and Mannatech. It also faces vitamin brands, mass merchants, marketplaces, subscription startups, and private labels. Hiya is sensitive to digital acquisition and retention; Rise is sensitive to retailer bargaining power and shelf productivity.

Competitive set Primary pressure USANA response Research implication
Herbalife and Nu Skin Brand Partner recruitment, incentives, global reach Science positioning, localized operations, compensation-plan changes Watch active customers and incentives as a percentage of Core sales.
LifeVantage, Nature’s Sunshine, Mannatech Specialized wellness products and distributor attention Broader portfolio, manufacturing scale, long operating history Moat depends on execution rather than exclusive technology.
Digital vitamin subscriptions Customer acquisition cost, retention, product convenience Hiya brand, refill model, expanded product line, retail tests Subscriber quality and marketing efficiency matter more than gross additions alone.
Protein snack and beverage brands Retail shelf access, pricing, velocity, retailer concentration Protein Pop innovation and national club-store distribution Fast sales growth can still destroy value if gross margin remains too low.

Market position is credible but not dominant

USANA is strongest where scientific branding, manufacturing control, and relationship distribution reinforce one another. It is weaker where consumers compare substitutes on price, reviews, convenience, or shelf placement. Rivalry and substitution are high; retailer power matters in Rise; paid acquisition matters in Hiya. The defense is a capability portfolio, not one exclusive asset.

How strong are USANA’s balance sheet, cash flow, and capital allocation?

FY2025 baseline
$925.3M revenue
8.3% reported growth, driven by the full-year inclusion of Hiya; Core Nutritional declined.
Q1 2026 signal
5.5% operating margin
Down from 6.3% in Q1 2025 as segment mix and profitability remained challenging.

Liquidity is a strength. At April 4, 2026, USANA held $162.8 million of cash against $14.0 million drawn on a $75.0 million revolver, and attributable equity was $543.6 million. Covenants require rolling EBITDA of at least $80.0 million through July 4, 2026 and $100.0 million thereafter, with funded debt no greater than 2.0 times EBITDA. The financial-results archive contains the reporting packages.

$148.8MQ1 2026 net cash position, calculated as $162.8M of cash less $14.0M of credit-facility debt.

Cash conversion weakened in FY2025

FY2025 operating cash flow fell to $22.3 million from $61.0 million. After $13.8 million of capex, approximate free cash flow was $8.5 million. USANA repurchased $27.5 million of stock, helping reduce cash from $181.8 million to $158.4 million. No shares were repurchased in Q1 2026; $34.0 million remained authorized at FY2025 year-end.

Capital item Amount Period Analytical reading
Operating cash flow $22.3M FY2025 Lower earnings and working-capital needs reduced cash generation.
Capital expenditures $13.8M FY2025 Manufacturing and operating infrastructure require moderate reinvestment.
Share repurchases $27.5M FY2025 Buybacks supported per-share ownership but used more cash than approximate free cash flow.
R&D expense $10.7M FY2025 Product science is strategically important but modest relative to revenue.
Advertising expense $43.2M FY2025 The full-year Hiya contribution materially increased paid acquisition spending.

Who owns USANA stock, and what are the governance implications?

USANA has one common share class, but ownership is concentrated. The 2026 proxy statement reported 18,456,935 shares outstanding on March 16, 2026. Gull Global, associated with founder interests, held 7,408,345 shares, or 40.1%, creating substantial influence without an absolute majority.

Holder or group Shares Ownership Why it matters
Gull Global, Ltd. 7,408,345 40.1% Founder-affiliated concentration can shape strategic continuity and shareholder votes.
Renaissance Technologies 1,147,323 6.2% A significant quantitative institutional position, based on year-end filing data.
Pzena Investment Management 1,134,429 6.1% Value-oriented institutional ownership can increase focus on cash returns and recovery.
Vanguard Group 934,316 5.1% Passive ownership adds institutional monitoring but limited direct strategic control.
Directors and officers as a group 150,517 Less than 1% Management’s direct economic stake is modest relative to the founder-affiliated block.

Leadership returned to an experienced operator

Kevin Guest returned as CEO in January 2026 while remaining chairman. His long tenure brings sales-network knowledge, but the combined roles increase the importance of independent oversight. Seven of eight director nominees were classified as independent. The CEO ownership guideline is five times base salary; other executive officers target one times salary. The leadership announcement emphasized faster growth and shareholder value.

What opportunities, risks, and valuation drivers matter most?

The opportunity set is broader than the legacy network

Core active customers
Q1 2026 was 404,000, down 12.0%. Stabilization would improve volume, factory utilization, and incentive efficiency.
Hiya subscribers and recurring mix
Q1 2026 subscribers were 186,000, down from 224,000. Retention and recurring orders drive better unit economics.
Rise gross margin
Q1 2026 gross margin was 7.1%. Retail scale must translate into better manufacturing and product economics.
China performance
China generated $112.5M in Q1 2026, about 45.0% of consolidated sales, making regulation and demand decisive.
Consolidated operating margin
Q1 2026 was 5.5%. The model needs Core resilience plus declining losses in Hiya and Rise.
Cash conversion
Monitor operating cash flow less capex and working-capital needs before judging buyback capacity.

Opportunities include Hiya’s expansion into Canada and the United Kingdom, Rise’s retail rollout, new products, and India. FY2026 guidance calls for $925 million to $1.0 billion of sales, $20.3 million to $26.6 million of net earnings, and $101.3 million to $109.3 million of adjusted EBITDA. Diversification may stabilize sales before restoring margins.

The most material risks are operational and regulatory

Risk Current evidence Financial line affected What to monitor
Core customer attrition Active customers fell 12.0% year over year in Q1 2026. Revenue, factory utilization, gross margin Regional customer trends and average spend.
China regulation and concentration BabyCare operates under evolving direct-selling rules and limited provincial licenses. Sales, cash remittance, legal cost Licensing, enforcement, meeting restrictions, and data rules.
Hiya integration and subscriber decline Subscribers fell 17.0%; the segment lost $2.6M in Q1 2026. SG&A, intangible amortization, goodwill Retention, marketing efficiency, retail contribution, and minority-interest obligations.
Rise retail economics Sales rose 740.7%, but gross margin was only 7.1% in Q1 2026. Gross profit, receivables, working capital Product velocity, retailer concentration, manufacturing cost, and mix.
Tax-rate volatility Effective tax rate was 55.0% in Q1 2026 and 72.4% in FY2025. Net income and EPS Geographic income mix and U.S. profitability.

A DCF should model Core customer change and spend, channel gross margins, Brand Partner incentives, Hiya marketing efficiency, Rise margin normalization, tax, working capital, and Hiya minority-interest obligations. Fast retail growth with weak margins may create less value than a stable direct-selling base. Subscriber stabilization and narrower segment losses could improve cash flow quickly because central infrastructure already exists.

Which customer and geographic KPIs best explain performance?

Stable consolidated revenue can conceal diverging operating engines. Q1 2026 Core active customers fell to 404,000 from 459,000, while average spend increased 5.6%. Greater China represented 235,000 customers, or 58.2% of the Core base. China generated $112.5 million of consolidated sales versus $63.5 million from the United States, linking growth, regulation, tax, currency, and cash availability.

Core Nutritional active-customer mix — Q1 2026
Greater China235,000 · 58.2%
Americas & Europe78,000 · 19.3%
Southeast Asia Pacific59,000 · 14.6%
North Asia32,000 · 7.9%
Greater China dominates the customer base. Period: quarter ended April 4, 2026.

A compact KPI formula set

  • Core revenue growth is principally active-customer change plus average-spend change, adjusted for currency and mix.
  • Hiya profitability depends on active subscribers, first-order versus recurring-order mix, customer acquisition spending, and fulfillment economics.
  • Rise contribution depends on retail sell-through, gross margin, trade receivables, manufacturing efficiency, and product concentration in Protein Pop.
  • Free cash flow equals operating cash flow less purchases of property and equipment; Q1 2026 was approximately $7.1 million.
  • Net margin was about 3.0% in Q1 2026 using $7.5 million of attributable earnings divided by $250.2 million of sales.

What is the key takeaway from USANA analysis?

USANA is a case study in business-model transition. Manufacturing, product development, global operations, and relationship distribution remain valuable, supported by net cash. Yet Core is contracting, Hiya subscribers declined, and Rise’s retail growth carried very low gross margin. The decisive question is whether omnichannel growth produces sustainable contribution profit and cash.

Support comes from Core profitability, a $148.8 million Q1 2026 net-cash position, retail distribution and experienced leadership. Pressure comes from customer attrition, China regulation, acquisition integration, tax volatility, margin dilution, and concentrated founder-affiliated ownership.

Final synthesis
For students, USANA illustrates how a company can diversify distribution without immediately improving economics. For researchers and investors, the decisive evidence will be Core active-customer stabilization, Hiya subscriber retention and marketing efficiency, Rise gross-margin expansion, consolidated operating-margin recovery, and free-cash-flow discipline. Those variables—not headline omnichannel sales alone—determine whether the transformation strengthens or weakens long-term value.

DCF model

    5-Year Financial Model

    40+ Charts & Metrics

    DCF & Multiple Valuation

    Free Email Support



Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.

(USNA) USANA Health Sciences, Inc. Bundle

Get Full Bundle:
$17 $9
$9 $5
$9 $5
$9 $5
$9 $5
$9 $5
$9 $5
$9 $5
$9 $5